IWT helps to accelerate reMYND’s Diabetes program with a grant of 1.48 million EUR for 2011-2012
29-Jun-2011 -
reMYND NV announced that it has received a grant of 1.48 million EUR from IWT, the Flemish agency for Innovation by Science and Technology, to accelerate its Diabetes program. reMYND’s Drug Discovery & Development focuses on the development of disease-modifying drugs for patients suffering from ...
drug discovery
type 2 diabetes